ANI Pharmaceuticals (ANIP) closed the last trading session at $58.64, gaining 1.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $77 indicates a 31.3% upside potential.The mean estimate comprises five short-term price targets with a standard deviation of $12.39. While the lowest estimate of $62 indicates a 5.7% increase from the current price level, the most optimistic analyst ex ...